ENCell

456070 · KOSDAQ · Health Care · SMALL CAP

Updated contract terms.

ENCell updated a previously disclosed supply contract, now worth US$1.27M, about 26.6% of its recent annual revenue, running through Aug 2027.

Supply contract([Amended] Supply contract signed)· FILED 2026-06-01· RCEPT 20260601901426

US$1.27MContract value
26.6%vs. recent revenue
Aug 2027Throughfrom Jul 2025

Converted at 1 USD ≈ ₩1,511.27 (filing-date rate, 2026-06-01 close)

What happened

ENCell updated a previously disclosed supply contract, now worth US$1.27M, about 26.6% of its recent annual revenue, running through Aug 2027.

For context, this single contract equals about 26.6% of the company's most recent annual revenue.

CounterpartyDisclosed
Contract valueUS$1.27M
vs. recent revenue26.6%
ThroughAug 2027 (from Jul 2025)
Filed2026-06-01, [Amended] Supply contract signed
SourceDART rcept 20260601901426 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-01 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.